RxDoctor Payments Data

Gen Shinozaki, MD

Psychiatry · Stanford, CANPI 1255474979

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (52.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Every reported general payment came from a single manufacturer, Sumitomo Pharma Co., Ltd.. Reporting peaked in 2019 at $1,428 and has fallen 99.2% since, to $12 in 2024.

$1,541in general payments, 2019–2025

Across 10 payments — averaging $154.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma Co., Ltd.$2K
$648,544in research payments, 2019–2025

Across 2 payments — averaging $324,272 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sumitomo Pharma Co., Ltd.$649K

What the payments were for

  • Speaking & faculty fees$81053%
  • Travel & lodging$69445%
  • Food & beverage$372%

General payments by program year

19
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sumitomo Pharma Co., Ltd.10$1,541

How this compares

$1,541 in reported general payments places this provider in the 80th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California →

Medicare billing

Part B allowed, 2024
$11,833
Medicare patients
45
Services billed
157

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other psychiatry in Stanford

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →